HDB Q1 2026 Earnings EPS Beats Estimates Amidst Market Skepticism NAT Q4 2025 Earnings EPS Misses Estimates by 56 Amid Weak Tanker Market Atossa Therapeutics Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Advances OCCI Q1 2026 Earnings Deep EPS Miss Overshadowed by Positive Market Reaction ACM Q1 2026 Earnings AECOM Beats Estimates on Solid EPS Performance Despite Missing Revenue Details GOVX Q1 2026 Earnings Narrower Loss Surprises Shares Surge Over 32